It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...

NDAQ:VRTX) Lost Money on Vertex Pharmaceuticals Incorporated (VRTX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky ...

Its first treatment, Casgevy, earned approval from the Food and Drug Administration (FDA ... The company's collaboration partner, Vertex Pharmaceuticals(NASDAQ: VRTX), made progress activating ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at ...

Vertex Pharmaceuticals Inc. closed $108.22 short of its 52-week high ($519.88), which the company achieved on November 8th.

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 1.52% on an annualized basis producing an ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The company anticipates launching three CRISPR products by 2030, including therapies for hereditary angioedema and ...

Akums Drugs & Pharmaceuticals Ltd. share price moved up by 0.14% from its previous close of Rs 617.40. Akums Drugs & Pharmaceuticals Ltd. stock last traded price is 618.25 ...